McKinsey Exec On Where India Innovation Could Head, Leveraging Pharma’s GCC Ecosystem

McKinsey & Company’s senior partner and lead, life sciences practice (Asia), talks to Scrip about innovation niches that could interest Indian firms including the ADC space, using AI to increase confidence in research activities and how India could leverage big pharma’s expanding global capability centres (GCCs) to shape the wider R&D ecosystem.

McKinsey & Company senior partner & lead, life sciences practice (Asia), Sathya Prathipati • Source: McKinsey & Co

More from R&D

More from Scrip